ArticleJournal of medical case reports2025
Diagnostic challenges of dermatomyositis in a resource-limited setting: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDermatomyositis is a rare idiopathic inflammatory myopathy characterized by distinct cutaneous manifestations and progressive proximal muscle weakness. However, in areas with limited diagnostic tools without a high index of suspicion, early identification is often challenging, increasing the risk of complications. CASE PRESENTATION: We report the case of a 50-year-old Ethiopian woman who presented with progressive difficulty swallowing, proximal muscle weakness, and characteristic dermatologic manifestations. Despite multiple emergency visits and extensive workups, such as chest computed tomography and barium swallow, the diagnosis was delayed. Key findings included elevated muscle enzymes and low serum albumin, and a muscle biopsy revealed muscle fiber atrophy. The diagnosis of dermatomyositis was confirmed by the American College of Rheumatology-European League Against Rheumatism classification criteria. MANAGEMENT: We treated the patient with high-dose prednisolone and methotrexate as a steroid-sparing agent, along with nutritional support. Her muscle strength and dysphagia significantly improved within weeks of therapy initiation.
conclusionOur goal is to emphasize the importance of early recognition of dermatomyositis, especially in resource-limited settings, to avoid unnecessary, financially debilitating workups and prevent complications such as malnutrition, which are completely avoidable with early detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.